Blueberry’s CEO John Ridden was interviewed by Times writer Michael Cape.

John and Michael spoke about how Blueberry benefitted from AstraZeneca’s move to Cambridge, which led to husband and wife team David and Julie Cook (CSO and Principal Scientist) joining Blueberry in 2014.

Read the article here:

Julie Cook, one half of the husband and wife team, said “Although David and I both worked for AstraZeneca for a number of years, we have always worked in different departments. This is the first time we’ve worked closely together professionally. It’s great to be doing that in a small, exciting company”.